Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Julphar
UBS
AstraZeneca
Federal Trade Commission
Johnson and Johnson
Farmers Insurance
Daiichi Sankyo
Baxter
Harvard Business School

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,134,122

« Back to Dashboard

Summary for Patent: 5,134,122
Title: Method for preparing a pharmaceutical composition in the form of microparticles
Abstract:A method for preparing a pharmaceutical composition in the form of microparticles, the composition thus obtained and its use for preparing injectable suspensions.
Inventor(s): Orsolini; Piero (Martigny, CH)
Assignee: Debiopharm S.A. (Lausanne, CH)
Application Number:07/555,973
Patent Claim Types:
see list of patent claims
Composition; Process; Use;

Drugs Protected by US Patent 5,134,122

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,134,122

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Switzerland2829/89Jul 28, 1989

International Patents Family Members for US Patent 5,134,122

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria A154590 ➤ Subscribe
Austria 397197 ➤ Subscribe
Austria A223591 ➤ Subscribe
Austria 397198 ➤ Subscribe
Australia 619996 ➤ Subscribe
Australia 5910390 ➤ Subscribe
Belgium 1003093 ➤ Subscribe
Belgium 1004923 ➤ Subscribe
Canada 2021767 ➤ Subscribe
Canada 2055115 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Mallinckrodt
Teva
Fuji
Baxter
Daiichi Sankyo
Argus Health
Merck
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot